Events After the End of the Reporting Period
Increasing the plan assets of Bayer Pension Trust e.V.
On April 19, 2016, Bayer AG increased the coverage of Bayer Pension Trust e.V. with the deposit of 10 million of the shares it held in Covestro AG. The number of shares deposited amounted to 4.9% of the shares outstanding.
Repayment of financial liabilities
On April 4, 2016, Bayer Nordic SE repaid on schedule a bond with a nominal volume of €200 million.
Patent term extension for rivaroxaban
In April 2016, the U.S. Patent and Trademark Office granted a patent term extension for rivaroxaban (the active pharmaceutical ingredient of Xarelto™). The patent protection of the active ingredient in the United States now expires in 2024.
Leverkusen, April 22, 2016
The Board of Management
Dr. Marijn Dekkers
Dr. Hartmut Klusik